Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Association of Matched Sibling Donor Hematopoietic Stem Cell Transplantation With Transcranial Doppler Velocities in Children With Sickle Cell Anemia.

Bernaudin F, Verlhac S, Peffault de Latour R, Dalle JH, Brousse V, Petras E, Thuret I, Paillard C, Neven B, Galambrun C, Divialle-Doumdo L, Pondarré C, Guitton C, Missud F, Runel C, Jubert C, Elana G, Ducros-Miralles E, Drain E, Taïeb O, Arnaud C, Kamdem A, Malric A, Elmaleh-Bergès M, Vasile M, Leveillé E, Socié G, Chevret S; DREPAGREFFE Trial Investigators.

JAMA. 2019 Jan 22;321(3):266-276. doi: 10.1001/jama.2018.20059.

PMID:
30667500
2.

Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos-channelopathy: A retrospective series of 126 patients.

Picard V, Guitton C, Thuret I, Rose C, Bendelac L, Ghazal K, Aguilar-Martinez P, Badens C, Barro C, Bénéteau C, Berger C, Cathébras P, Deconinck E, Delaunay J, Durand JM, Firah N, Galactéros F, Godeau B, Jaïs X, de Jaureguiberry JP, Le Stradic C, Lifermann F, Maffre R, Morin G, Perrin J, Proulle V, Ruivard M, Toutain F, Lahary A, Garçon L.

Haematologica. 2019 Jan 17. pii: haematol.2018.205328. doi: 10.3324/haematol.2018.205328. [Epub ahead of print]

3.

Late effects after hematopoietic stem cell transplantation for β-thalassemia major: the French national experience.

Rahal I, Galambrun C, Bertrand Y, Garnier N, Paillard C, Frange P, Pondarré C, Dalle JH, de Latour RP, Michallet M, Steschenko D, Moshous D, Lutz P, Stephan JL, Rohrlich PS, Yakoub-Agha I, Bernaudin F, Piguet C, Aladjidi N, Badens C, Berger C, Socié G, Dumesnil C, Castex MP, Poirée M, Lambilliotte A, Thomas C, Simon P, Auquier P, Michel G, Loundou A, Agouti I, Thuret I.

Haematologica. 2018 Jul;103(7):1143-1149. doi: 10.3324/haematol.2017.183467. Epub 2018 Mar 29.

4.

Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations.

Besnard C, Levy E, Aladjidi N, Stolzenberg MC, Magerus-Chatinet A, Alibeu O, Nitschke P, Blanche S, Hermine O, Jeziorski E, Landman-Parker J, Leverger G, Mahlaoui N, Michel G, Pellier I, Suarez F, Thuret I, de Saint-Basile G, Picard C, Fischer A, Neven B, Rieux-Laucat F, Quartier P; Members of the French reference center for pediatric autoimmune cytopenias (CEREVANCE).

Clin Immunol. 2018 Mar;188:52-57. doi: 10.1016/j.clim.2017.12.009. Epub 2018 Jan 10.

PMID:
29330115
5.

Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia.

Bernaudin F, Pondarré C, Galambrun C, Thuret I.

Adv Exp Med Biol. 2017;1013:89-122. doi: 10.1007/978-1-4939-7299-9_4.

PMID:
29127678
6.

Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by transcranial Doppler (NCT 01340404).

Chevret S, Verlhac S, Ducros-Miralles E, Dalle JH, de Latour RP, de Montalembert M, Benkerrou M, Pondarré C, Thuret I, Guitton C, Lesprit E, Etienne-Julan M, Elana G, Vannier JP, Lutz P, Neven B, Galambrun C, Paillard C, Runel C, Jubert C, Arnaud C, Kamdem A, Brousse V, Missud F, Petras M, Doumdo-Divialle L, Berger C, Fréard F, Taieb O, Drain E, Elmaleh M, Vasile M, Khelif Y, Bernaudin M, Chadebech P, Pirenne F, Socié G, Bernaudin F.

Contemp Clin Trials. 2017 Nov;62:91-104. doi: 10.1016/j.cct.2017.08.008. Epub 2017 Aug 15.

PMID:
28821470
7.

[Biological diagnosis of iron deficiency in children].

Thuret I.

Arch Pediatr. 2017 May;24(5S):5S6-5S13. doi: 10.1016/S0929-693X(17)24003-2. Review. French.

PMID:
28622783
8.

Platelet and not erythrocyte microparticles are procoagulant in transfused thalassaemia major patients.

Agouti I, Cointe S, Robert S, Judicone C, Loundou A, Driss F, Brisson A, Steschenko D, Rose C, Pondarré C, Bernit E, Badens C, Dignat-George F, Lacroix R, Thuret I.

Br J Haematol. 2015 Nov;171(4):615-24. doi: 10.1111/bjh.13609. Epub 2015 Jul 24.

PMID:
26205481
9.

A mutation in the Gardos channel is associated with hereditary xerocytosis.

Rapetti-Mauss R, Lacoste C, Picard V, Guitton C, Lombard E, Loosveld M, Nivaggioni V, Dasilva N, Salgado D, Desvignes JP, Béroud C, Viout P, Bernard M, Soriani O, Vinti H, Lacroze V, Feneant-Thibault M, Thuret I, Guizouarn H, Badens C.

Blood. 2015 Sep 10;126(11):1273-80. doi: 10.1182/blood-2015-04-642496. Epub 2015 Jul 6.

10.

[Information for parents of children with sickle cell trait detected by neonatal screening: A 10-year experience].

Joly P, Badens C, Fekih S, Philippe N, Merono F, Thuret I, Pondarré C.

Arch Pediatr. 2015 May;22(5):562-3. doi: 10.1016/j.arcped.2015.02.020. Epub 2015 Apr 1. French. No abstract available.

PMID:
25842198
11.

Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island.

Muszlak M, Pissard S, Badens C, Chamouine A, Maillard O, Thuret I.

Hemoglobin. 2015;39(3):156-61. doi: 10.3109/03630269.2015.1023897. Epub 2015 Mar 25.

PMID:
25806420
12.

[Clinical management of beta-thalassaemia].

Thuret I.

Rev Prat. 2014 Oct;64(8):1132-7. French.

PMID:
25510144
13.

A genetic score for the prediction of beta-thalassemia severity.

Danjou F, Francavilla M, Anni F, Satta S, Demartis FR, Perseu L, Manca M, Sollaino MC, Manunza L, Mereu E, Marceddu G, Pissard S, Joly P, Thuret I, Origa R, Borg J, Forni GL, Piga A, Lai ME, Badens C, Moi P, Galanello R.

Haematologica. 2015 Apr;100(4):452-7. doi: 10.3324/haematol.2014.113886. Epub 2014 Dec 5.

14.

[Current management of thalassemia intermedia].

Thuret I.

Transfus Clin Biol. 2014 Nov;21(4-5):143-9. doi: 10.1016/j.tracli.2014.07.005. Epub 2014 Oct 2. French.

PMID:
25282488
15.

Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD).

Chakraborty PK, Schmitz-Abe K, Kennedy EK, Mamady H, Naas T, Durie D, Campagna DR, Lau A, Sendamarai AK, Wiseman DH, May A, Jolles S, Connor P, Powell C, Heeney MM, Giardina PJ, Klaassen RJ, Kannengiesser C, Thuret I, Thompson AA, Marques L, Hughes S, Bonney DK, Bottomley SS, Wynn RF, Laxer RM, Minniti CP, Moppett J, Bordon V, Geraghty M, Joyce PB, Markianos K, Rudner AD, Holcik M, Fleming MD.

Blood. 2014 Oct 30;124(18):2867-71. doi: 10.1182/blood-2014-08-591370. Epub 2014 Sep 5.

16.

MRI monitoring of myocardial iron overload: use of cardiac MRI combined with hepatic MRI in a cohort of multi-transfused patients with thalassaemia.

Quatre A, Jacquier A, Petit P, Giorgi R, Thuret I.

Diagn Interv Imaging. 2014 Nov;95(11):1065-9. doi: 10.1016/j.diii.2014.01.007. Epub 2014 Jul 4.

17.

Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.

Angelucci E, Matthes-Martin S, Baronciani D, Bernaudin F, Bonanomi S, Cappellini MD, Dalle JH, Di Bartolomeo P, de Heredia CD, Dickerhoff R, Giardini C, Gluckman E, Hussein AA, Kamani N, Minkov M, Locatelli F, Rocha V, Sedlacek P, Smiers F, Thuret I, Yaniv I, Cavazzana M, Peters C; EBMT Inborn Error and EBMT Paediatric Working Parties.

Haematologica. 2014 May;99(5):811-20. doi: 10.3324/haematol.2013.099747.

18.

Peripheral blood cells chimerism after unrelated cord blood transplantation in children: kinetics, predictive factors and impact on post-transplant outcome.

Elkaim E, Picard C, Galambrun C, Barlogis V, Loundou A, Curtillet C, Oudin C, Thuret I, Chambost H, Michel G.

Br J Haematol. 2014 Aug;166(4):557-65. doi: 10.1111/bjh.12918. Epub 2014 Apr 29.

PMID:
24779895
19.

Marseillevirus prevalence in multitransfused patients suggests blood transmission.

Popgeorgiev N, Colson P, Thuret I, Chiarioni J, Gallian P, Raoult D, Desnues C.

J Clin Virol. 2013 Dec;58(4):722-5. doi: 10.1016/j.jcv.2013.10.001. Epub 2013 Oct 15.

PMID:
24183312
20.

Iron overload of hematological origin: validation of a screening procedure for cardiac overload by MRI in routine clinical practice.

Ernst O, Thuret I, Petit P, Ameur F, Loundou AD, de Kerviler E, Izzillo R, Willig AL, Pascal L, Verlhac S, Mordon S, Fenaux P, Rose C.

Diagn Interv Imaging. 2013 Jun;94(6):601-8. doi: 10.1016/j.diii.2013.03.005. Epub 2013 May 13.

21.

Post-transfusional iron overload in the haemoglobinopathies.

Thuret I.

C R Biol. 2013 Mar;336(3):164-72. doi: 10.1016/j.crvi.2012.09.010. Epub 2012 Oct 24. Review.

PMID:
23643400
22.

A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD).

Wiseman DH, May A, Jolles S, Connor P, Powell C, Heeney MM, Giardina PJ, Klaassen RJ, Chakraborty P, Geraghty MT, Major-Cook N, Kannengiesser C, Thuret I, Thompson AA, Marques L, Hughes S, Bonney DK, Bottomley SS, Fleming MD, Wynn RF.

Blood. 2013 Jul 4;122(1):112-23. doi: 10.1182/blood-2012-08-439083. Epub 2013 Apr 3.

23.

Long-term red blood cell exchange in children with sickle cell disease: manual or automatic?

Duclos C, Merlin E, Paillard C, Thuret I, Demeocq F, Michel G, Kanold J.

Transfus Apher Sci. 2013 Apr;48(2):219-22. doi: 10.1016/j.transci.2012.09.002. Epub 2012 Dec 19.

PMID:
23257506
24.

Persistence of natural killer cells with expansion of a hypofunctional CD56-CD16+KIR+NKG2C+ subset in a patient with atypical Janus kinase 3-deficient severe combined immunodeficiency.

Farnault L, Chambost H, Michel G, Thuret I, de Saint Basile G, Fischer A, Picard C, Picard C, Orlanducci F, Farnarier C, Moretta A, Olive D.

J Allergy Clin Immunol. 2013 Apr;131(4):1230-3, 1233.e1-2. doi: 10.1016/j.jaci.2012.08.047. Epub 2012 Oct 12. No abstract available.

PMID:
23069490
25.

French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions.

Galambrun C, Pondarré C, Bertrand Y, Loundou A, Bordigoni P, Frange P, Lutz P, Mialou V, Rubie H, Socié G, Schneider P, Bernaudin F, Paillard C, Michel G, Badens C, Thuret I; French Rare Disease Center for Thalassemia; French Society of Bone Marrow Transplantation.

Biol Blood Marrow Transplant. 2013 Jan;19(1):62-8. doi: 10.1016/j.bbmt.2012.08.005. Epub 2012 Aug 11.

26.

Rare duplication or deletion of exons 6, 7 and 8 in CYBB leading to X-linked chronic granulomatous disease in two patients from different families.

Stasia MJ, van Leeuwen K, de Boer M, Martel C, Mollin M, Thuret I, Michel G, Hanson C, Augustine NH, Coutton C, Satre V, Wittwer CT, Hill H, Roos D.

J Clin Immunol. 2012 Aug;32(4):653-62. doi: 10.1007/s10875-012-9667-2. Epub 2012 Mar 2.

PMID:
22382877
27.

Variants in genetic modifiers of β-thalassemia can help to predict the major or intermedia type of the disease.

Badens C, Joly P, Agouti I, Thuret I, Gonnet K, Fattoum S, Francina A, Simeoni MC, Loundou A, Pissard S.

Haematologica. 2011 Nov;96(11):1712-4. doi: 10.3324/haematol.2011.046748. Epub 2011 Jul 26.

28.

Lopinavir/ritonavir population pharmacokinetics in neonates and infants.

Urien S, Firtion G, Anderson ST, Hirt D, Solas C, Peytavin G, Faye A, Thuret I, Leprevost M, Giraud C, Lyall H, Khoo S, Blanche S, Tréluyer JM.

Br J Clin Pharmacol. 2011 Jun;71(6):956-60. doi: 10.1111/j.1365-2125.2011.03926.x.

29.

Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia.

Oudin C, Simeoni MC, Sirvent N, Contet A, Begu-Le Coroller A, Bordigoni P, Curtillet C, Poirée M, Thuret I, Play B, Massot MC, Chastagner P, Chambost H, Auquier P, Michel G.

Blood. 2011 Apr 28;117(17):4442-8. doi: 10.1182/blood-2010-09-304899. Epub 2011 Jan 28.

30.

Impact of viable CD45 cells infused on lymphocyte subset recovery after unrelated cord blood transplantation in children.

Barlogis V, Glasman L, Brunet C, Loundou AD, Lemarie C, Galambrun C, Thuret I, Curtillet C, Le Meignen M, Bernard F, Chambost H, Calmels B, Picard C, Chabannon C, Dignat-George F, Michel G.

Biol Blood Marrow Transplant. 2011 Jan;17(1):109-16. doi: 10.1016/j.bbmt.2010.06.016. Epub 2010 Jun 25.

31.

Neonatal screening for sickle cell disease in France: evaluation of the selective process.

Thuret I, Sarles J, Merono F, Suzineau E, Collomb J, Lena-Russo D, Levy N, Bardakdjian J, Badens C.

J Clin Pathol. 2010 Jun;63(6):548-51. doi: 10.1136/jcp.2009.068874.

PMID:
20498028
32.

Complications and treatment of patients with β-thalassemia in France: results of the National Registry.

Thuret I, Pondarré C, Loundou A, Steschenko D, Girot R, Bachir D, Rose C, Barlogis V, Donadieu J, de Montalembert M, Hagege I, Pegourie B, Berger C, Micheau M, Bernaudin F, Leblanc T, Lutz L, Galactéros F, Siméoni MC, Badens C.

Haematologica. 2010 May;95(5):724-9. doi: 10.3324/haematol.2009.018051. Epub 2009 Dec 8.

33.

Socio-psychological impact of infused iron chelation therapy with deferoxamine in metropolitan France: ISOSFER study results.

Thuret I, Hacini M, Pégourié-Bandelier B, Gardembas-Pain M, Bisot-Locard S, Merlat-Guitard A, Bachir D.

Hematology. 2009 Dec;14(6):315-22. doi: 10.1179/102453309X12473408860424.

PMID:
19941737
34.

[Beta-thalassemia major: what is the situation in France?].

Badens C, Thuret I.

Rev Prat. 2009 Oct 20;59(8):1048-50. French. No abstract available.

PMID:
19894438
35.

Raltegravir, etravirine and r-darunavir combination in adolescents with multidrug-resistant virus.

Thuret I, Chaix ML, Tamalet C, Reliquet V, Firtion G, Tricoire J, Rabaud C, Frange P, Aumaître H, Blanche S.

AIDS. 2009 Nov 13;23(17):2364-6. doi: 10.1097/QAD.0b013e328331a456.

PMID:
19823069
36.

[Current concepts in the management of transfusional iron overload].

Thuret I, Barlogis V, Michel G.

Arch Pediatr. 2009 Jun;16(6):559-61. doi: 10.1016/S0929-693X(09)74066-7. French. No abstract available.

PMID:
19541084
37.

[Hereditary spherocytosis: guidelines for the diagnosis and management in children].

Guitton C, Garçon L, Cynober T, Gauthier F, Tchernia G, Delaunay J, Leblanc T, Thuret I, Bader-Meunier B.

Arch Pediatr. 2009 Jun;16(6):556-8. doi: 10.1016/S0929-693X(09)74065-5. French. No abstract available.

PMID:
19541083
38.

Height growth during adolescence and final height after haematopoietic SCT for childhood acute leukaemia: the impact of a conditioning regimen with BU or TBI.

Bernard F, Bordigoni P, Simeoni MC, Barlogis V, Contet A, Loundou A, Thuret I, Leheup B, Chambost H, Play B, Auquier P, Michel G.

Bone Marrow Transplant. 2009 Apr;43(8):637-42. doi: 10.1038/bmt.2008.370. Epub 2008 Nov 17.

PMID:
19011662
39.

First case of gamma-thalassemia in association with a betaS allele: a pitfall in the neonatal screening for sickle cell disease.

Lacoste C, Bonello-Palot N, Gonnet K, Merono F, Levy N, Thuret I, Badens C.

Haematologica. 2008 Nov;93(11):1754-5. doi: 10.3324/haematol.13262. Epub 2008 Aug 25. No abstract available.

40.

[Hereditary spherocytosis: guidelines for the diagnosis and management in children].

Guitton C, Garçon L, Cynober T, Gauthier F, Tchernia G, Delaunay J, Leblanc T, Thuret I, Bader-Meunier B.

Arch Pediatr. 2008 Sep;15(9):1464-73. doi: 10.1016/j.arcped.2008.04.023. Epub 2008 Jun 16. French.

PMID:
18556182
41.

Vertical transmission of multidrug-resistant Q151M human immunodeficiency virus type 1 strains.

Henry M, Thuret I, Solas C, Genot S, Colson P, Tamalet C.

Pediatr Infect Dis J. 2008 Mar;27(3):278-80. doi: 10.1097/INF.0b013e31815db4c6.

PMID:
18277921
42.

Health status and quality of life in long-term survivors of childhood leukaemia: the impact of haematopoietic stem cell transplantation.

Michel G, Bordigoni P, Simeoni MC, Curtillet C, Hoxha S, Robitail S, Thuret I, Pall-Kondolff S, Chambost H, Orbicini D, Auquier P.

Bone Marrow Transplant. 2007 Nov;40(9):897-904. Epub 2007 Aug 20.

PMID:
17704791
43.

Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease.

Bernaudin F, Socie G, Kuentz M, Chevret S, Duval M, Bertrand Y, Vannier JP, Yakouben K, Thuret I, Bordigoni P, Fischer A, Lutz P, Stephan JL, Dhedin N, Plouvier E, Margueritte G, Bories D, Verlhac S, Esperou H, Coic L, Vernant JP, Gluckman E; SFGM-TC.

Blood. 2007 Oct 1;110(7):2749-56. Epub 2007 Jul 2.

44.

CD34(+) progenitors are reproducibly recovered in thawed umbilical grafts, and positively influence haematopoietic reconstitution after transplantation.

Lemarie C, Esterni B, Calmels B, Dazey B, Lapierre V, Lecchi L, Meyer A, Rea D, Thuret I, Chambost H, Curtillet C, Chabannon C, Michel G.

Bone Marrow Transplant. 2007 Apr;39(8):453-60. Epub 2007 Mar 5.

PMID:
17334384
45.

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.

Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, Aydinok Y, Kattamis A, Kilinc Y, Porter J, Capra M, Galanello R, Fattoum S, Drelichman G, Magnano C, Verissimo M, Athanassiou-Metaxa M, Giardina P, Kourakli-Symeonidis A, Janka-Schaub G, Coates T, Vermylen C, Olivieri N, Thuret I, Opitz H, Ressayre-Djaffer C, Marks P, Alberti D.

Blood. 2006 May 1;107(9):3455-62. Epub 2005 Dec 13.

46.

[Evans' syndrome: a retrospective study from the ship (French Society of Pediatric Hematology and Immunology) (36 cases)].

Blouin P, Auvrignon A, Pagnier A, Thuret I, Antoni G, Bader-Meunier B, Le Deist F, Chastagner P, Aladjidi N, Pellier I, Bertrand Y, Behar C, Landmann-Parker J, Leverger G, Perel Y.

Arch Pediatr. 2005 Nov;12(11):1600-7. Epub 2005 Sep 26. French.

PMID:
16185853
47.

Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group.

Perel Y, Auvrignon A, Leblanc T, Michel G, Reguerre Y, Vannier JP, Dalle JH, Gandemer V, Schmitt C, Méchinaud F, Lejars O, Piguet C, Couillaud G, Pautard B, Landman-Parker J, Thuret I, Aladjidi N, Baruchel A, Leverger G; French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group.

Leukemia. 2005 Dec;19(12):2082-9.

PMID:
16121218
48.

Clinical and laboratory manifestations of congenital dyserythropoietic anemia type I in a cohort of French children.

Bader-Meunier B, Leverger G, Tchernia G, Schischmanoff O, Cynober T, Bernaudin F, Leblanc T, Munzer M, Roda L, Soler C, Thuret I, Delaunay J.

J Pediatr Hematol Oncol. 2005 Aug;27(8):416-9.

PMID:
16096522
49.
50.

Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.

Donadieu J, Leblanc T, Bader Meunier B, Barkaoui M, Fenneteau O, Bertrand Y, Maier-Redelsperger M, Micheau M, Stephan JL, Phillipe N, Bordigoni P, Babin-Boilletot A, Bensaid P, Manel AM, Vilmer E, Thuret I, Blanche S, Gluckman E, Fischer A, Mechinaud F, Joly B, Lamy T, Hermine O, Cassinat B, Bellanné-Chantelot C, Chomienne C; French Severe Chronic Neutropenia Study Group.

Haematologica. 2005 Jan;90(1):45-53.

Supplemental Content

Loading ...
Support Center